These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22586351)

  • 1. Kras, Pten, NF-κB, and inflammation: dangerous liaisons.
    Chiao PJ; Ling J
    Cancer Discov; 2011 Jul; 1(2):103-5. PubMed ID: 22586351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.
    Ying H; Elpek KG; Vinjamoori A; Zimmerman SM; Chu GC; Yan H; Fletcher-Sananikone E; Zhang H; Liu Y; Wang W; Ren X; Zheng H; Kimmelman AC; Paik JH; Lim C; Perry SR; Jiang S; Malinn B; Protopopov A; Colla S; Xiao Y; Hezel AF; Bardeesy N; Turley SJ; Wang YA; Chin L; Thayer SP; DePinho RA
    Cancer Discov; 2011 Jul; 1(2):158-69. PubMed ID: 21984975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.
    Döppler H; Panayiotou R; Reid EM; Maimo W; Bastea L; Storz P
    Sci Rep; 2016 Sep; 6():33758. PubMed ID: 27649783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability.
    Schneider G; Weber A; Zechner U; Oswald F; Friess HM; Schmid RM; Liptay S
    Int J Cancer; 2006 May; 118(10):2405-11. PubMed ID: 16353139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
    Siddique HR; Liao DJ; Mishra SK; Schuster T; Wang L; Matter B; Campbell PM; Villalta P; Nanda S; Deng Y; Saleem M
    Int J Cancer; 2012 Oct; 131(7):1720-31. PubMed ID: 22190076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy.
    Lin YK; Fang Z; Jiang TY; Wan ZH; Pan YF; Ma YH; Shi YY; Tan YX; Dong LW; Zhang YJ; Wang HY
    Cancer Lett; 2018 May; 421():161-169. PubMed ID: 29452147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
    Flandez M; Cendrowski J; Cañamero M; Salas A; del Pozo N; Schoonjans K; Real FX
    Gut; 2014 Apr; 63(4):647-55. PubMed ID: 23598351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
    Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
    Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.
    Ichikawa T; Nakahata S; Fujii M; Iha H; Morishita K
    Sci Rep; 2015 Aug; 5():12841. PubMed ID: 26269411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
    Keklikoglou I; Hosaka K; Bender C; Bott A; Koerner C; Mitra D; Will R; Woerner A; Muenstermann E; Wilhelm H; Cao Y; Wiemann S
    Oncogene; 2015 Sep; 34(37):4867-78. PubMed ID: 25500542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential.
    Wartenberg M; Centeno I; Haemmig S; Vassella E; Zlobec I; Galván JA; Neuenschwander M; Schlup C; Gloor B; Lugli A; Perren A; Karamitopoulou E
    Eur J Cancer; 2016 Sep; 65():80-90. PubMed ID: 27475963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.
    Ma Q; Wu X; Wu J; Liang Z; Liu T
    Int J Oncol; 2017 Oct; 51(4):1104-1114. PubMed ID: 28902358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
    Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
    Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.